BME News
February 9, 2024
Purdue BME welcomes Estelle Park, PhD
Estelle Park, PhD has joined the Weldon School of Biomedical Engineering as an Assistant Professor. Her research is best known for growing stem cell-derived organoids in physiologically relevant microenvironments through microengineered organ-chip devices to study tissue morphogenesis and identify biomarkers in diseases.
Be sure to say hello when you see her out with her adorable dog Noah.
Be sure to say hello when you see her out with her adorable dog Noah.
February 9, 2024
EMBRIO Institute comes to High Alpha in Indianapolis
Krishna Jayant, assistant professor in the Weldon School of Biomedical Engineering at Purdue, presents his group’s research to other researchers from multiple disciplines during the two-day EMBRIO institute retreat at High Alpha in Indianapolis. The slide highlights the work Jayant and student Shulan Xiao are doing to “uncover the rules via which neurons multiplex information across multiple dendrites.”
February 9, 2024
Advancing Personalized Audiology Through Mechanistic Cross-Species Auditory Neuroscience
In the heart of Indiana, where the rhythm of farming machinery meets the winds of progress, Purdue University is at the forefront of an innovative audiology exploration.
February 8, 2024
NIH provides funding to improve prediction of heart disease progression in pediatric patients with Duchenne muscular dystrophy
Purdue Professors Craig Goergen and Guang Lin team up with medical centers around the country and receive $3.6 Million NIH grant to improve heart disease detection in kids with Duchenne Muscular Dystrophy using advanced imaging and machine learning.
February 2, 2024
Robinson presents to the Board of Trustees
Robinson reports on developments in portable foodborne pathogen and blood-based disease detection in his presentation to the Purdue Board of Trustees.
January 31, 2024
Adipo Therapeutics completes $1.9M seed funding bridge to advance obesity and Type 2 diabetes treatment
Adipo is a privately held, late-stage, preclinical biopharmaceutical company developing a breakthrough approach to treat the dual epidemics of obesity and Type 2 diabetes. Adipo has identified a lead asset, ADPO-002, that combines a notch inhibitor with novel nanoparticle technology. ADPO-002 is specifically designed to infiltrate and release the active ingredient inside the cellular structure of white adipose tissue, which results in mitochondrial biogenesis and the beiging of white adipose tissue. Meng Deng is the founder and president of Adipo Therapeutics. He also is an associate professor in Purdue University’s Department of Agricultural and Biological Engineering, Weldon School of Biomedical Engineering and School of Materials Engineering.
January 30, 2024
Faculty Spotlight: Steve Steinhubl, MD
He may be an MD, not a PhD, but his research on the development of individualized digital biomarkers made possible by wearable sensors may change the face of healthcare.
January 25, 2024
Lee awarded $50,000 to bring blood clot device to market
Hugh Lee is one of four researches at Purdue to receive the Trask Innovation Fund. The fund awards up to $50,000 for short-term projects that enhance the commercial value of Purdue intellectual property.
January 23, 2024
Students design drone to save lives from opioid overdose
VIP team designs Narcan delivery drone to bring aid to remote communities